Gestational hypertension nursing: assessment, management, and NCLEX tips

Gestational hypertension is the most common hypertensive disorder of pregnancy, affecting 6–17% of nulliparous women and 2–4% of multiparous women. Despite being defined by the absence of the most dangerous features seen in preeclampsia, it is far from benign: up to half of cases diagnosed before 34 weeks will progress to preeclampsia, and severe-range blood pressures carry the same acute risk of stroke and maternal death regardless of the diagnostic label attached to them. For nursing students, gestational hypertension sits at the center of several high-yield NCLEX concepts — distinguishing it from preeclampsia, knowing when blood pressure thresholds mandate intervention, and understanding the postpartum surveillance window that catches late deterioration.

This reference walks through the diagnostic criteria, nursing assessment priorities, antihypertensive management, fetal surveillance strategies, and postpartum considerations. For the full preeclampsia spectrum including HELLP syndrome and eclampsia, see the preeclampsia nursing reference.

Quick reference: hypertensive disorders of pregnancy

Diagnostic criteria

Gestational hypertension is defined by three positive criteria and three negative criteria. All must be present for the diagnosis to stand.

Positive criteria (all three required):

• Systolic BP ≥140 mmHg OR diastolic BP ≥90 mmHg
• Documented on two separate occasions at least 4 hours apart
• Onset after 20 weeks’ gestation in a woman with previously normal blood pressure

The 4-hour interval requirement exists to exclude transient, positional, or anxiety-related blood pressure elevation. In clinical practice, if a patient presents with BP ≥160/110 and symptoms, you should not wait 4 hours — this is a medical emergency regardless of diagnosis. ACOG Committee Opinion 767 specifies that severe-range values require treatment within 30–60 minutes of confirmation, and a 15-minute interval between readings suffices for the severe-range threshold.

Negative criteria (all three must be absent):

• No proteinuria (less than 300 mg in a 24-hour urine collection, protein:creatinine ratio less than 0.3, or urine dipstick less than 2+)
• No end-organ damage (normal creatinine, platelet count above 100,000/µL, normal liver enzymes, no pulmonary edema, no new-onset headache unresponsive to medication, no visual disturbance)
• No severe features (as defined by ACOG Practice Bulletin 222, 2020)

The distinction between gestational hypertension and preeclampsia is clinically meaningful because it drives very different management decisions: magnesium sulfate for seizure prophylaxis, inpatient admission intensity, and delivery timing all hinge on whether the patient has progressed beyond gestational hypertension. For a deeper breakdown of how these diagnoses interact with HELLP syndrome, see the obstetric nursing reference.

Resolution: Gestational hypertension resolves by 12 weeks postpartum. If blood pressure remains elevated beyond 12 weeks, the diagnosis is reclassified as chronic hypertension.

Nursing assessment

Blood pressure monitoring

Accurate, consistent blood pressure measurement is the foundation of gestational hypertension management. Several nursing actions directly affect the validity of readings:

• Use a validated, calibrated cuff appropriate to arm circumference. An undersized cuff falsely elevates readings; an oversized cuff falsely lowers them.
• Position the patient seated, arm at heart level, after at least 5 minutes of rest. Lateral decubitus position is appropriate for laboring patients; document the position used.
• For outpatient management, ACOG recommends BP checks twice weekly at minimum for non-severe gestational hypertension. Document both readings, timestamps, and symptoms at each visit.
• Inpatient patients with non-severe values are typically monitored every 4–6 hours; any reading in the severe range (≥160/110) triggers immediate notification and treatment initiation.

Fetal surveillance

Because gestational hypertension reduces uteroplacental perfusion, fetal wellbeing is monitored alongside maternal blood pressure throughout the pregnancy.

• Non-stress test (NST): Weekly from diagnosis. An NST assesses fetal heart rate reactivity and provides indirect evidence of adequate oxygen delivery. A reactive NST (two accelerations of at least 15 bpm for at least 15 seconds within a 20-minute window) is reassuring.
• Biophysical profile (BPP): Used as a backup or when NST is non-reactive. Scores breathing movement, body movement, tone, amniotic fluid index, and NST reactivity (total score out of 10). A score of 8–10 is reassuring; 6 is equivocal and usually triggers repeat testing or delivery consideration; 4 or less warrants urgent evaluation.
• Umbilical artery Doppler: Used selectively when fetal growth restriction is suspected. Absent or reversed end-diastolic flow indicates severe uteroplacental insufficiency and requires immediate escalation.
• Growth ultrasound: Every 3–4 weeks to monitor for fetal growth restriction, a recognized complication of gestational hypertension due to impaired placental perfusion.
• Amniotic fluid index (AFI): Oligohydramnios (AFI less than 5 cm or deepest vertical pocket less than 2 cm) can accompany deteriorating uteroplacental function.

Laboratory surveillance

The primary nursing concern when monitoring labs in a patient with gestational hypertension is detecting the laboratory shift that signals progression to preeclampsia. The labs to track include:

• CBC: Platelets below 100,000/µL signals HELLP syndrome territory and reclassification to preeclampsia with severe features. Hemoconcentration (rising hematocrit) may reflect reduced plasma volume.
• Comprehensive metabolic panel (CMP): Creatinine above 1.1 mg/dL or doubling of baseline is a severe feature. AST/ALT elevation above twice the upper limit of normal indicates hepatic involvement.
• Liver function tests (LFTs): Epigastric or right upper quadrant pain should always prompt LFT review — this is a symptom of subcapsular hepatic hemorrhage in HELLP syndrome.
• Uric acid: While not part of the formal ACOG diagnostic criteria, hyperuricemia (uric acid above 5.5–6 mg/dL in pregnancy) has been identified as an early marker of progression to preeclampsia and is commonly tracked in clinical practice. Rising uric acid warrants heightened surveillance.
• 24-hour urine protein or spot protein:creatinine ratio: A spot P:Cr ratio of 0.3 or greater is diagnostic of proteinuria sufficient to reclassify the patient as having preeclampsia.

Report immediately to the provider:

• Any BP reading ≥160/110 mmHg
• New headache unresponsive to acetaminophen
• Visual disturbances (blurred vision, scotoma, photophobia)
• Epigastric or RUQ pain
• Sudden facial or hand edema
• Decreased or absent fetal movement
• Platelet count below 150,000/µL or falling trend
• Any proteinuria on dipstick (2+ or greater) confirmed on repeat

For information on interpreting lab value trends in complex OB patients, see the nursing lab values cheat sheet.

Management

Blood pressure thresholds and treatment timing

The decision to initiate antihypertensive medication is driven by the severity of the readings, not by the diagnostic label. The threshold for acute treatment is severe-range blood pressure: SBP ≥160 mmHg OR DBP ≥110 mmHg.

ACOG Committee Opinion 767 establishes that severe-range blood pressures during pregnancy or the postpartum period require pharmacologic treatment within 30–60 minutes of confirmation. This is a patient safety mandate: untreated severe-range hypertension is a leading cause of maternal stroke and death in the peripartum period. The nurse’s role is to:

1. Confirm the reading with a repeat measurement within 15 minutes
2. Notify the provider immediately
3. Prepare and administer the ordered antihypertensive promptly
4. Reassess blood pressure 20–30 minutes after administration
5. Document response and notify if target not reached (typically SBP 140–160, DBP 90–105)

Non-severe gestational hypertension (SBP 140–159, DBP 90–109) is generally managed with increased surveillance rather than pharmacologic treatment, depending on gestational age and clinical stability. Some providers initiate oral antihypertensives in this range for patients with comorbidities or those approaching term.

Delivery timing

Delivery is the definitive treatment for gestational hypertension. ACOG Practice Bulletin 222 recommends delivery at 37 weeks’ gestation for gestational hypertension. Earlier delivery may be indicated if the patient develops severe features or her condition deteriorates.

Inpatient versus outpatient management for non-severe gestational hypertension depends on clinical stability, gestational age, and the patient’s ability to comply with home monitoring and return precautions.

Antihypertensive medications

A critical NCLEX and clinical point: sublingual nifedipine is absolutely contraindicated in pregnancy. The sublingual route bypasses first-pass metabolism and delivers nifedipine too rapidly, causing a precipitous drop in maternal blood pressure that severely reduces uteroplacental perfusion and can precipitate fetal distress. The oral route, with its more gradual absorption, achieves effective blood pressure reduction without this risk.

Regarding magnesium sulfate: MgSO4 is a seizure prophylaxis agent used in preeclampsia with severe features. It has no role in gestational hypertension without severe features. Administering MgSO4 to a patient with gestational hypertension would be inappropriate and would carry toxicity risks without clinical benefit. This distinction is heavily tested on NCLEX.

Postpartum considerations

Gestational hypertension does not automatically resolve at delivery. The early postpartum period, particularly the first 3–5 days after birth, carries a significant risk of blood pressure worsening as fluid shifts redistribute following delivery. Some patients who had well-controlled blood pressures during pregnancy will develop their highest readings postpartum.

Postpartum monitoring priorities:

• Assess blood pressure every 4 hours for the first 72 hours postpartum in patients with a history of gestational hypertension during the admission
• Educate the patient before discharge on severe-range BP symptoms: persistent headache, visual changes, epigastric pain, and significant swelling — and when to return to care
• ACOG recommends a blood pressure check within 72 hours of discharge and again at 7–10 days for patients with hypertensive disorders of pregnancy
• Postpartum oral antihypertensives may be needed even if the patient did not require them antepartum

Resolution timeline:

Gestational hypertension resolves within 12 weeks postpartum in the vast majority of patients. If blood pressure remains elevated beyond 12 weeks, the diagnosis is reclassified as chronic hypertension, and the patient should be referred for ongoing primary care or cardiology follow-up.

Postpartum hemorrhage risk:

Severe hypertension and antihypertensive therapy can interact with uterotonic agents used for postpartum hemorrhage management. Ergotamine derivatives (methylergonovine) are contraindicated in patients with hypertension because they cause vasoconstriction and can precipitate a hypertensive crisis. Oxytocin remains safe and is the first-line uterotonic. For a full review of postpartum hemorrhage management, see the postpartum hemorrhage nursing reference.

Long-term risk:

Women with a history of gestational hypertension have a significantly elevated risk of developing chronic hypertension, cardiovascular disease, and stroke later in life compared to women with normotensive pregnancies. This is an important counseling point at discharge. The data from long-term studies suggests gestational hypertension functions as a “stress test” that unmasks underlying vascular susceptibility.

NCLEX high-yield tips

1. The three-criteria rule for gestational hypertension

The diagnosis requires: SBP ≥140 OR DBP ≥90, confirmed on two readings at least 4 hours apart, after 20 weeks’ gestation. If any of the three is missing, the diagnosis does not stand. On NCLEX, watch for scenarios that mention only one reading or onset before 20 weeks.

2. Absence findings define the diagnosis

Gestational hypertension is defined as much by what is absent as by what is present. No proteinuria. No end-organ damage. No severe features. The moment any of these appears, the patient has progressed to preeclampsia. NCLEX scenarios will describe a patient with gestational hypertension and then introduce new symptoms — your job is to recognize the progression.

3. Severe-range BP requires treatment within 30–60 minutes regardless of diagnosis

A patient with gestational hypertension who develops BP ≥160/110 has severe-range hypertension. The treatment urgency is identical to preeclampsia with severe features. Do not delay antihypertensive therapy waiting to reclassify the diagnosis. ACOG Committee Opinion 767 is unambiguous: severe-range BP requires pharmacologic intervention within 30–60 minutes.

4. Sublingual nifedipine is absolutely contraindicated

If an NCLEX question presents a nurse preparing to administer sublingual nifedipine to a pregnant patient with hypertension, the answer is to refuse and question the order. The sublingual route causes an uncontrolled precipitous BP drop that can cause fetal distress. Oral nifedipine is appropriate; sublingual is not.

5. Magnesium sulfate is NOT indicated in gestational hypertension without severe features

MgSO4 is for seizure prophylaxis in preeclampsia with severe features. It is not an antihypertensive, and it has no role in gestational hypertension. NCLEX frequently tests this distinction. If a question asks which intervention is appropriate for gestational hypertension, MgSO4 alone is never the correct answer unless the patient has progressed to preeclampsia with severe features.

6. Up to 50% of cases diagnosed before 34 weeks will progress to preeclampsia

Early-onset gestational hypertension (before 34 weeks) carries a high risk of progression. These patients require more intensive surveillance. On NCLEX, a patient diagnosed with gestational hypertension at 28 weeks should be recognized as high-risk for progression, making surveillance questions a priority.

7. Delivery at 37 weeks is the definitive management

For stable gestational hypertension, delivery is recommended at 37 weeks’ gestation. Before 37 weeks, the goal is to prolong the pregnancy with close surveillance (twice-weekly BP checks, weekly NST, growth ultrasound every 3–4 weeks). On NCLEX, if asked about the management priority for a patient at 36 weeks with stable gestational hypertension, the answer is continued outpatient surveillance rather than immediate delivery.

8. The postpartum period is a high-risk window

BP worsening in the first 3–5 days after delivery is common and expected in patients with gestational hypertension. Educating the patient about warning signs (headache, visual changes, epigastric pain, swelling) and providing clear return instructions are mandatory nursing actions before discharge.

9. Uric acid elevation is an early warning signal

While not formally part of the ACOG diagnostic criteria, rising uric acid in a patient with gestational hypertension is associated with increased risk of progression to preeclampsia. Documenting and reporting an upward trend in uric acid prompts closer surveillance.

10. Persistent hypertension beyond 12 weeks postpartum = chronic hypertension

If blood pressure has not normalized by 12 weeks after delivery, the diagnosis is reclassified as chronic hypertension. NCLEX may test this reclassification timeline. Know it: 12 weeks is the cutoff.

Related resources

Gestational hypertension sits within a broader OB cluster of conditions that nursing students commonly study together. The conditions that most closely interact with gestational hypertension management include:

• Preeclampsia nursing reference — covers diagnostic progression from gestational hypertension, HELLP syndrome, MgSO4 management, and eclampsia
• HELLP syndrome — the laboratory constellation that can develop from gestational hypertension or preeclampsia
• Obstetric nursing reference — broad OB framework including labor stages, fetal monitoring, and hypertensive disorder overview
• Gestational diabetes nursing — the other major pregnancy-specific metabolic condition; often co-occurs with gestational hypertension
• Postpartum hemorrhage nursing — essential postpartum management, including the ergotamine contraindication relevant to hypertensive patients
• PROM and PPROM nursing — covers preterm rupture of membranes, which may intersect with early-onset gestational hypertension management decisions

Clinical references: ACOG Practice Bulletin 222 (2020): Gestational Hypertension and Preeclampsia; ACOG Committee Opinion 767 (2019): Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period; Magee LA et al., NEJM 2022 (CHIPS Trial — tight vs less-tight BP control in pregnancy); StatPearls: Gestational Hypertension (2024); Gabbe SJ et al., Obstetrics: Normal and Problem Pregnancies, 8th ed.